@article{Šahinović_Huskić_Kauković_2021, title={Factor V Leiden homozygous mutation: Recurrent venous thromboembolism during periods of discontinuation of anticoagulant therapy}, volume={11}, url={https://www.jhsci.ba/ojs/index.php/jhsci/article/view/1283}, DOI={10.17532/jhsci.2021.1283}, abstractNote={<p>Venous thromboembolism (VTE), also known as deep vein thrombosis and pulmonary thromboembolism, is a medical condition that has a high incidence and a multifactorial pathogenesis. One of the causes is a mutation of the Factor V Leiden (FVL), which is the most common inherited thrombotic disorder. A mutation inherited from both parents is found in about 0.05-0.5% of cases, making our case more medically interesting. We presented the case of a young male patient with recurrent VTE and few risk factors who was admitted to the hospital 4 times with VTE symptoms over a 5-year period. In the background, there was a homozygous FVL mutation and improper use of anticoagulant therapy. We examined the medical data, diagnostics, therapy, and precautions that were and are required.</p>}, number={2}, journal={Journal of Health Sciences}, author={Šahinović, Sabira and Huskić, Vildana and Kauković, Adis}, year={2021}, month={Sep.}, pages={137–141} }